Ohguri Takayuki, Imada Hajime, Kohshi Kiyotaka, Kakeda Shingo, Ohnari Norihiro, Morioka Tomoaki, Nakano Keita, Konda Nobuhide, Korogi Yukunori
Department of Radiology, University of Occupational and Environmental Health, Iseigaoka, Kitakyushu, Japan.
Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):248-55. doi: 10.1016/j.ijrobp.2006.08.009.
The purpose of the present study was to evaluate the prophylactic effect of hyperbaric oxygen (HBO) therapy for radiation-induced brain injury in patients with brain metastasis treated with stereotactic radiosurgery (SRS).
The data of 78 patients presenting with 101 brain metastases treated with SRS between October 1994 and September 2003 were retrospectively analyzed. A total of 32 patients with 47 brain metastases were treated with prophylactic HBO (HBO group), which included all 21 patients who underwent subsequent or prior radiotherapy and 11 patients with common predictors of longer survival, such as inactive extracranial tumors and younger age. The other 46 patients with 54 brain metastases did not undergo HBO (non-HBO group). The radiation-induced brain injuries were divided into two categories, white matter injury (WMI) and radiation necrosis (RN), on the basis of imaging findings.
The radiation-induced brain injury occurred in 5 lesions (11%) in the HBO group (2 WMIs and 3 RNs) and in 11 (20%) in the non-HBO group (9 WMIs and 2 RNs). The WMI was less frequent for the HBO group than for the non-HBO group (p = 0.05), although multivariate analysis by logistic regression showed that WMI was not significantly correlated with HBO (p = 0.07). The 1-year actuarial probability of WMI was significantly better for the HBO group (2%) than for the non-HBO group (36%) (p < 0.05).
The present study showed a potential value of prophylactic HBO for the radiation-induced WMIs, which justifies further evaluation to confirm its definite benefit.
本研究旨在评估高压氧(HBO)疗法对接受立体定向放射外科治疗(SRS)的脑转移瘤患者放射性脑损伤的预防效果。
回顾性分析1994年10月至2003年9月间接受SRS治疗的78例患者共101个脑转移瘤的数据。共有32例患者的47个脑转移瘤接受了预防性HBO治疗(HBO组),其中包括所有21例接受过后续或先前放疗的患者以及11例具有较长生存期常见预测因素的患者,如颅外肿瘤不活跃和年龄较轻。另外46例患者的54个脑转移瘤未接受HBO治疗(非HBO组)。根据影像学表现,将放射性脑损伤分为两类,即白质损伤(WMI)和放射性坏死(RN)。
HBO组有5个病灶(11%)发生放射性脑损伤(2例WMI和3例RN),非HBO组有11个病灶(20%)发生放射性脑损伤(9例WMI和2例RN)。HBO组的WMI发生率低于非HBO组(p = 0.05),尽管logistic回归多因素分析显示WMI与HBO无显著相关性(p = 0.07)。HBO组WMI的1年精算概率(2%)明显优于非HBO组(36%)(p < 0.05)。
本研究显示预防性HBO对放射性WMI具有潜在价值,这为进一步评估以确认其确切益处提供了依据。